Skip to main content
Livermore
Livermore
ZHEN

Novem Group

SEC CIK
0001926783
Latest filing
Jul 21, 2026

The latest 13F from Novem Group covers Q2 2026 (filed Jul 21, 2026): 437 long positions worth $986.1M. The top 10 holdings make up 25.9% of the portfolio, and the largest is PIMCO ETF Tr at 4.2%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
64
Est. +$53.0M
Added
178
Est. +$95.3M
Reduced
167
Est. −$51.3M
Sold out
51
Est. −$61.3M

Top 5 holdings

Share of this quarter's portfolio value

  1. PIMCO ETF Tr72201R585
    4.2%$41.7M
  2. Schwab U.S. Large-Cap Growth ETF808524300
    4.1%$40.3M
  3. State Street SPDR Portfolio S&P 500 ETF78464A854
    2.9%$28.3M
  4. Fidelity Covington Trust316092360
    2.8%$27.4M
  5. PIMCO Active Bond Exchange-Traded Fund72201R775
    2.3%$22.6M

Biggest buys

New and added positions, by estimated amount bought

  1. PIMCO ETF Tr72201R585
    +$34.2MAdded
  2. Capital Group GBL Growth EQT14020X104
    +$7.47MAdded
  3. First Tr Exchng Traded FD VI33740U273
    +$5.70MNew
  4. AZNAstraZeneca PLC
    +$4.74MNewHistory
  5. Invesco Nasdaq 100 ETF46138G649
    +$4.22MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. PIMCO ETF Tr72201R585
    +3.37 pp0.9% → 4.2%
  2. Capital Group GBL Growth EQT14020X104
    +0.78 pp0.2% → 1.0%
  3. First Tr Exchng Traded FD VI33740U273
    +0.58 pp0.0% → 0.6%
  4. AZNAstraZeneca PLC
    +0.48 pp0.0% → 0.5%History
  5. Invesco Nasdaq 100 ETF46138G649
    +0.45 pp0.2% → 0.6%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Ibonds Dec 2029 Term Corporate ETF46436E205
    −$12.8MSold out
  2. Vanguard Scottsdale FDS92206C102
    −$11.1MSold out
  3. PIMCO Enhanced Short Maturity Active Exchange-Traded Fund72201R833
    −$10.2MReduced
  4. Vanguard High Dividend Yield Index ETF921946406
    −$6.01MReduced
  5. TGTTarget Corp
    −$4.38MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Ibonds Dec 2029 Term Corporate ETF46436E205
    −1.48 pp1.5% → 0.0%
  2. PIMCO Enhanced Short Maturity Active Exchange-Traded Fund72201R833
    −1.41 pp3.2% → 1.8%
  3. Vanguard Scottsdale FDS92206C102
    −1.28 pp1.3% → 0.0%
  4. Vanguard High Dividend Yield Index ETF921946406
    −0.75 pp2.3% → 1.6%
  5. TGTTarget Corp
    −0.47 pp0.5% → <0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$986.1M
+$116.5M (+13.4%) vs. prior quarter
Positions
437
+13 vs. prior quarter
Top 10 concentration
25.9%
Top 10 as share of value
Turnover
12.1%
Q2 2026, one quarter
Average holding period
6.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $986.1M (Q2 2026)

Q4 2024: $672.6MQ1 2025: $708.3MQ2 2025: $787.9MQ3 2025: $839.2MQ4 2025: $863.7MQ1 2026: $869.7MQ2 2026: $986.1M
Q4 2024Q2 2026
13F filings of Novem Group by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 21, 2026437$986.1MPIMCO ETF TrSchwab U.S. Large-Cap Growth ETFState Street SPDR Portfolio S&P 500 ETFvs. Q1 2026SEC
Q1 2026Apr 13, 2026424$869.7MSchwab U.S. Large-Cap Growth ETFPIMCO Enhanced Short Maturity Active Exchange-Traded FundState Street SPDR Portfolio S&P 500 ETFvs. Q4 2025SEC
Q4 2025Jan 27, 2026406$863.7MSchwab U.S. Large-Cap Growth ETFVanguard Dividend Appreciation ETFPIMCO ETF Trvs. Q3 2025SEC
Q3 2025Nov 10, 2025399$839.2MSchwab U.S. Large-Cap Growth ETFPIMCO ETF TrVanguard Dividend Appreciation ETFvs. Q2 2025SEC
Q2 2025Jul 16, 2025389$787.9MSchwab U.S. Large-Cap Growth ETFVanguard Dividend Appreciation ETFState Street SPDR Portfolio S&P 500 ETFvs. Q1 2025SEC
Q1 2025Apr 28, 2025354$708.3MVanguard Dividend Appreciation ETFPIMCO ETF TrSchwab U.S. Large-Cap Growth ETFvs. Q4 2024SEC
Q4 2024Feb 18, 2025361$672.6MSchwab U.S. Large-Cap Growth ETFVanguard Dividend Appreciation ETFState Street SPDR Portfolio S&P 500 ETF–SEC